跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Caryophyllene
首页
药物
Caryophyllene
Investigational
Small Molecule
Caryophyllene
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
15
H
24
CAS 编号
87-44-5
UNII ID
NRY8I0KNIR
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cannabis plant named ‘LEMON CRUSH OG’
US PP31535 P3
申请人: BIOTECH INST LLC
优先权: 2018
US
8 件公开
Masking agent
US 12575590 B2
申请人: AJINOMOTO KK
优先权: 2020
CN
EP
US
WO
5 件公开
COMPOSITION FOR TREATING VASCULAR DISEASE, COMPOSITION FOR PREVENTING VASCULAR DISEASE, COMPOSITION FOR TREATING HYPERTENSION, AND COMPOSITION FOR PREVENTING HYPERTENSION
EP 4241768 A4
申请人: UNIV KINKI
优先权: 2020
CN
EP
US
WO
4 件公开
CARYOPHYLLENE-CONTAINING COMPOSITION
EP 4403169 A4
申请人: SUNSHO PHARMACEUTICAL CO LTD
优先权: 2021
CN
EP
US
WO
4 件公开
EP 4403170 A4
申请人: SUNSHO PHARMACEUTICAL CO LTD
优先权: 2021
CN
EP
US
WO
4 件公开
AN ANTI-INFLAMMATORY COMPOSITION FOR THE TREATMENT OF ACUTE JOINT INFLAMMATION AND A PROCESS FOR PREPARATION THEREOF
EP 3500282 B1
申请人: AUREA BIOLABS PRIVATE LTD
优先权: 2016
EP
US
WO
4 件公开
SELF-EMULSIFYING COMPOSITIONS OF CB2 RECEPTOR MODULATORS
EP 3423033 A4
申请人: ANAVI GOFFER SHARON
优先权: 2016
EP
US
4 件公开
LIQUID COMPOSITIONS COMPRISING TERPENES AND CANNABINOIDS
EP 4081208 A4
申请人: BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD
优先权: 2019
EP
US
WO
3 件公开
CARYOPHYLLENE-CONTAINING AGENT OR COMPOSITION AND VARIOUS APPLICATIONS THEREOF
US 2023200435 A1
申请人: UNIV KINKI
优先权: 2020
CN
US
WO
3 件公开
STABLE ORAL CANNABIDIOL COMPOSITIONS
EP 4255494 A4
申请人: CARDIOL THERAPEUTICS INC
优先权: 2020
EP
US
WO
3 件公开
COMPOSITION FOR PROMOTING GLP-1 SECRETION
EP 4309515 A4
申请人: NAGASE VIITA CO LTD
优先权: 2021
EP
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈